Vor Biopharma Inc 10-Q for FY2026 Q3
Vor Biopharma Inc. (VOR)
10-Q
2026-10-30
For: 2026-09-30
View Original
Added on
October 30, 2026
About this 10-Q
Vor Biopharma Inc filed this 10-Q on October 30, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Vor Biopharma completed UPSTREAM MG enrollment in September 2026, with topline data expected in the first half of 2027. It had $481.6 million of cash, cash equivalents and marketable securities as of September 30, 2026, expected to fund operations into early 2029. AI summary
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $86.73M
- compared with a net loss of $812.68M a year earlier
- Diluted EPS
- -$1.45
- compared with -$121.63 a year earlier